VHC - Virus Hépatologie Cancer | HENRI MONDOR

Soutenir la recherche
 

Sequencing activites for the characterization of viral genomes

Available Analyses

Manual, semi-automated, and automated methods are used for viral genome sequencing :

ANALYSIS

INDICATION

METHOD

REAGENTS



Genotyping of HBV


Clinical research

Molecular epidemiology


Sequencing the HBsAg coding region


 CNR Protocol


Genotyping of HBV resistance to antiviral drugs


Characterization of treatment failure of nucleoside/nucleotide analogues


Sequencing the reserve transcriptase coding region



CNR Protocol


Determining the genotype and sub-type of HCV



Pre-therapeutic assessment of HCV


Hybridization on a strip


Siemens ref.6719382


Genotyping of HCV resistance to antiviral drugs


Characterization of treatment failure based on the use of direct acting antiviral drugs


Sequencing the regions coding the proteins NS3, NS5A ans NS5B



CNR Protocol


Genotyping of HIV resistance to antiviral drugs


Characterization of treatment failure of antiretroviral drugs



ViroSeq


Abbott ref.4J9493



Characterization of the sequence of integrase


Approach to therapeutic decision

Characterization of integrase inhibitors in treatment failure




ViroSeq




Abbott ref.4J9471

Equipment

Materials used for viral genome sequencing are shared between the Laboratory of Virology and the genomic platform [Sanger and Next Generation sequencing (NGS)]. The equipment includes:

  • 1 AUTOBLOT 3000 automated system to analyze reversed hybrids (Siemens)
  • 1 Auto-LiPA 48 (Innogenetics)
  • 3 ABI PRISM 3100 automatic capillary sequencers (Applied Biosystems)
  • 1 GS FLX + (Roche - 454 Sequencing)
  • 1 MiSeq DX (Illumina)
  • 2 NextSeq 500 (Illumina)
  • 1 Ion Proton (Life Technologie)
  • 1 Agilent 2100 Bioanalyzer (Agilent Technologies)
  • 3 Veriti thermocyclers (Applied Biosystems)
  • 1 CASY TT (Roche Diagnostics)
  • 1 TissueLysser (Qiagen)